BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31408004)

  • 21. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
    Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
    J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
    Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
    Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
    Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.
    Maloney E; Wang YN; Vohra R; Son H; Whang S; Khokhlova T; Park J; Gravelle K; Totten S; Hwang JH; Lee D
    World J Gastroenterol; 2020 Mar; 26(9):904-917. PubMed ID: 32206002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
    Kaissis G; Ziegelmayer S; Lohöfer F; Algül H; Eiber M; Weichert W; Schmid R; Friess H; Rummeny E; Ankerst D; Siveke J; Braren R
    Eur Radiol Exp; 2019 Oct; 3(1):41. PubMed ID: 31624935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer.
    Han Z; Zhang S; Fujiwara K; Zhang J; Li Y; Liu J; van Zijl PCM; Lu ZR; Zheng L; Liu G
    Bioconjug Chem; 2019 May; 30(5):1425-1433. PubMed ID: 30938983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiological evaluation of pancreatic ductal adenocarcinoma].
    Akai H; Otomo K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
    Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized
    Dutta P; Pando SC; Mascaro M; Riquelme E; Zoltan M; Zacharias NM; Gammon ST; Piwnica-Worms D; Pagel MD; Sen S; Maitra A; Shams S; McAllister F; Bhattacharya PK
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of pancreatic tumor development in KPC mice using multi-parametric MRI.
    Vohra R; Park J; Wang YN; Gravelle K; Whang S; Hwang JH; Lee D
    Cancer Imaging; 2018 Nov; 18(1):41. PubMed ID: 30409175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
    Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
    Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging for pancreatic ductal adenocarcinoma.
    Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
    Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.
    Daemen A; Peterson D; Sahu N; McCord R; Du X; Liu B; Kowanetz K; Hong R; Moffat J; Gao M; Boudreau A; Mroue R; Corson L; O'Brien T; Qing J; Sampath D; Merchant M; Yauch R; Manning G; Settleman J; Hatzivassiliou G; Evangelista M
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4410-7. PubMed ID: 26216984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R
    Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-ray phase-contrast CT of a pancreatic ductal adenocarcinoma mouse model.
    Tapfer A; Braren R; Bech M; Willner M; Zanette I; Weitkamp T; Trajkovic-Arsic M; Siveke JT; Settles M; Aichler M; Walch A; Pfeiffer F
    PLoS One; 2013; 8(3):e58439. PubMed ID: 23536795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
    Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
    Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
    Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric MR imaging detects therapy efficacy of radioactive seeds brachytherapy in pancreatic ductal adenocarcinoma xenografts.
    Liu Y; Wang Y; Tang W; Jiang M; Li K; Tao X
    Radiol Med; 2018 Jul; 123(7):481-488. PubMed ID: 29508241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.